In the heart of KEM Hospital's ICMR department at NIIH, Shweta Chawla, a dedicated PhD student engrossed in cell line research, experienced a moment that would redefine her career and impact countless lives.

On what seemed like a routine day, Shweta's attention was captured by a distraught couple navigating the busy hematology labs. Their young daughter, a major thalassemia patient, urgently needed a blood transfusion, pending an extended blood type report. The scene was all too familiar—a stark reminder of the critical healthcare gaps faced by many families.

As Shweta observed the overburdened lab technicians struggling to meet the pressing demands, she was struck by the harsh reality: crucial tests delayed due to overwhelming workloads, and essential services priced beyond reach at private labs. This disparity ignited a spark within her. Shweta knew she couldn’t stand by and accept the status quo. With her empathy and scientific curiosity driving her, Shweta resolved to bridge this gap in rapid, affordable blood group identification—a service with life-or-death implications

From Lab to Lifeline: The Birth of Soulsense Innovations Pvt Ltd

A Beacon of Hope

As Soulsense Innovations Pvt Ltd began to grow, Shweta’s unwavering commitment to equitable healthcare gained widespread recognition. Collaborations with healthcare professionals and strategic partnerships propelled her vision, delivering tangible impact within underserved communities.

Today, Soulsense Innovations Pvt Ltd stands as a beacon of hope, embodying the transformative power of innovation dedicated to social good. With every rapid blood typing test administered, lives are saved, and barriers to healthcare accessibility are dismantled—one breakthrough at a time.

Determined to make a difference, Shweta approached the institute's director and initiated a groundbreaking project. Harnessing her academic expertise, she developed pioneering reagents that revolutionized blood group typing. This innovation not only earned her an Indian patent but also laid the foundation for her startup, Soulsense Innovations Pvt Ltd.

With relentless passion, Shweta's startup moved forward, integrating cutting-edge technology to expedite blood group analysis while keeping it affordable. But her vision extended beyond diagnostics. She envisioned a comprehensive system to capture and store vital donor-recipient data, ensuring seamless healthcare coordination

Inception of innovation

Our Vision

"Democratizing Healthcare Diagnostics with Affordable and Accessible Technologies to Improve Global Health Outcomes and Ensure Equitable Healthcare for All"

Our Mission

"Develop and Deploy Innovative, User-Friendly Diagnostic Solutions to Bridge Healthcare Gaps and Empower Providers for Proactive Patient Care"

Our mission is to prioritize affordability, simplicity, and scalability, ensuring that our diagnostic technologies reach underserved communities, driving a positive impact on global health. We are committed to empowering healthcare providers with tools that enable proactive and effective patient care, bridging gaps and enhancing health outcomes worldwide.

Dr. Shweta Chawla

Leading Pharmaceutical Innovator with Expertise in Nanotechnology & Targeted Drug Delivery
Dr.Shweta Chawla is a distinguished pharmaceutical researcher with a PhD in Pharmaceutical Sciences from the Institute of Chemical Technology. With extensive expertise in nanotechnology, antibody-drug conjugates, and biopharmaceutics, she pioneers affordable and accessible healthcare solutions. As the Founder and CEO of Soulsense Innovations, she is committed to revolutionizing diagnostics and medical devices, making a lasting impact on global healthcare. Her work at the intersection of innovation and patient care is setting new standards in the pharmaceutical industry.

Founder and CEO

Soulsense Innovations Pvt Ltd

Dr Sushant Sahu

Dr. Sushant Sahu is a leading consultant specializing in nanotechnology, electrochemical energy conversion, and electrochemical sensors. With a rich academic background, including a postdoc from Louisiana State University and the University of Louisiana at Lafayette, USA, a Ph.D. from Clemson University, and an M.Sc. from IIT Guwahati, he brings cutting-edge expertise to the fields of ionic polymers and optical bioimaging. Dr. Sahu's innovative solutions are designed to transform industries through advanced technology and sustainable energy practices.

Dr. Sushant Sahu, Consultant in Nanotechnology and Electrochemical Sensors,

Ph.D. (Clemson University, USA), Postdoc (Louisiana State University and University of Louisiana at Lafayette, USA), M.Sc. (IIT Guwahati)

Dr. Arun V J

Dr. Arun V J is a highly skilled medical professional with extensive experience in Transfusion Medicine and Cellular Therapy. He holds an MD in Immunohematology & Blood Transfusion and is currently pursuing an MBA in Hospital and Healthcare System Management. With a passion for innovation and healthcare excellence, Dr. Arun has pioneered numerous blood donation initiatives and contributed to significant advancements in stem cell transplantation and blood center management. His research in Virtual Reality for blood donation showcases his commitment to integrating technology for enhanced patient care. Dr. Arun is an active member of international blood transfusion societies and a regular contributor to conferences, furthering knowledge in transfusion medicine

Consultant in Transfusion Medicine and Cellular Therapy

The Challenges of Conventional Blood Group Identification

The Critical Role of Blood Group Identification in Medical Care

Limitations of Conventional Blood Typing Methods

The Challenge of Automated Blood Group Analyzers

Hidden Complexities of Blood Types and Rare Donor Registry

Most people are only aware of their basic ABO blood type, yet there are other subtypes that have clinical importance. Lack of awareness of these subtypes can lead to serious health risks. Some rare blood types also require the establishment of specialized rare donor registries to ensure availability when needed.

Blood group identification is a vital component of medical processes, especially during emergencies, where blood transfusions are often needed. Correct blood typing can be the difference between life and death in critical situations such as trauma or life-threatening diseases.

BLOOD TRANSFUSIONS

The traditional methods for blood group identification, such as tube testing, slide testing, and gel cards, are time-consuming, costly, and require highly skilled personnel to operate effectively. This makes them impractical for smaller laboratories or clinics with limited resources.

While automated blood group analyzers offer greater efficiency, they come with significant downsides. These machines are large, expensive, and often imported into India, making it difficult for small laboratories to afford and accommodate them in limited spaces.

CANCER-PATIENTS

SURGERY

PREGNANCY COMPLICATIONS

ACCIDENTS AND OTHER CASAULTIES

THALASSEMIA & SICKLE CELL ANAEMIAS

PRETERM NEONATES

Revolutionizing Blood Group Identification

Portable, Point-of-Care Technology

Accurate and Quick Blood Typing

Convenient and User-Friendly

Cost-Effective Solution

Our innovative device brings blood group identification directly to the point of care. Unlike traditional methods, our portable solution is adaptable to various healthcare settings, including hospitals, clinics, mobile healthcare units, and blood banks, making it accessible and versatile for immediate use.

Experience rapid and accurate blood typing with our device. It significantly outperforms conventional methods such as the STD tube technique and Gel cards, ensuring that healthcare providers get precise results in record time, essential during emergencies and critical medical procedures

Our solution is designed for convenience, enabling its use in a wide range of medical environments. Whether in a hospital setting, mobile clinic, or remote healthcare unit, our device delivers reliable results with minimal setup, simplifying the blood typing process for all healthcare professionals.

We provide a cost-effective alternative to traditional blood typing methods. Our device is an affordable option for small labs and healthcare providers, reducing expenses without compromising on quality, making advanced diagnostics more accessible globally.